Rationale and study design of a randomized controlled trial to investigate the renoprotective effect of canagliflozin assessed by test of renal hemodynamics in diabetic kidney disease (the FAGOTTO study).
Sawako KatoYachiyo KuwatsukaMasahiko AndoYoshitaka TatematsuNobuhiro NishiboriShoichi MaruyamaPublished in: BMC nephrology (2023)
jRCT (Japan Registry Of Clinical Trials) jRCTs041200069. Date of registration: November 27, 2020.
Keyphrases